These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4606955)

  • 41. Gout.
    JAMA; 1973 Apr; 224(5 Suppl):757-66. PubMed ID: 4349285
    [No Abstract]   [Full Text] [Related]  

  • 42. [Therapy of gout].
    Fontana M
    Clin Ter; 1978 Feb; 84(4):441-7. PubMed ID: 648101
    [No Abstract]   [Full Text] [Related]  

  • 43. An evidence based appraisal of the management of nontophaceous interval gout.
    Ferraz MB
    J Rheumatol; 1995 Sep; 22(9):1618-9. PubMed ID: 8523332
    [No Abstract]   [Full Text] [Related]  

  • 44. The medical/surgical management of gout.
    Landry JR; Schilero J
    J Foot Surg; 1986; 25(2):160-75. PubMed ID: 3519742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gout and uric acid metabolism.
    Arthritis Rheum; 1970; 13(5):553-69. PubMed ID: 4922854
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of decrease in hyperuricemia levels on joint, kidney and other symptoms in patients with gout].
    Kawenoki-Minc E
    Ter Arkh; 1987; 59(4):25-8. PubMed ID: 3589999
    [No Abstract]   [Full Text] [Related]  

  • 47. [The treatment of gout and the internal medical treatment of uric acid nephrolithiasis].
    Zöllner N
    Dtsch Med Wochenschr; 1968 Feb; 93(7):310-2. PubMed ID: 4296298
    [No Abstract]   [Full Text] [Related]  

  • 48. [Gout: diagnosis and therapy].
    Schlapbach P
    Ther Umsch; 1985 Oct; 42(10):687-90. PubMed ID: 3909489
    [No Abstract]   [Full Text] [Related]  

  • 49. The influence of allopurinol on the course of gout. A study of 28 cases.
    Kawenoki-Minc E; Eyman E; Sopata I; Weryńska-Przybylska J
    Reumatologia; 1970; 8(3):177-92. PubMed ID: 5469423
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antarthritics. 41].
    Mayr E
    Pharm Prax; 1969 Dec; 12():267-9. PubMed ID: 4909745
    [No Abstract]   [Full Text] [Related]  

  • 51. Opportunities for improving medication use and monitoring in gout.
    Singh JA; Hodges JS; Asch SM
    Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GOUT.
    REAH TG
    Practitioner; 1964 Sep; 193():306-14. PubMed ID: 14213731
    [No Abstract]   [Full Text] [Related]  

  • 53. [The treatment of gout in the senile age].
    Silvi G; Pardini C
    Policlinico Med; 1971; 78(5):222-8. PubMed ID: 5131996
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of indomethacin and phenylbutazone in acute gout.
    Smyth CJ; Percy JS
    Ann Rheum Dis; 1973 Jul; 32(4):351-3. PubMed ID: 4726072
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical aspects of chronic gout].
    Otto W; Binder E
    Z Gesamte Inn Med; 1966 Sep; 21(18):562-7. PubMed ID: 5990726
    [No Abstract]   [Full Text] [Related]  

  • 56. Medical management of the patient with arthritis.
    Brandt KD
    Clin Orthop Relat Res; 1974 Jun; (101):13-27. PubMed ID: 4366334
    [No Abstract]   [Full Text] [Related]  

  • 57. Treating gout: successful methods of prevention and control.
    Talbott JH
    Postgrad Med; 1978 May; 63(5):175-80. PubMed ID: 643764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 59. [Gout (pathogenesis and therapy)].
    Chirone E
    Policlinico Prat; 1968 Feb; 75(6):177-87. PubMed ID: 5744779
    [No Abstract]   [Full Text] [Related]  

  • 60. Gout.
    Bayliss RI
    Br Med J; 1979 Jun; 1(6179):1695-6. PubMed ID: 466182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.